Published in Eur J Cancer on December 08, 2012
Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study. J Transl Med (2013) 0.84
Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget (2017) 0.75
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Virchows Arch (2017) 0.75
Current Management Strategy for Penile Cancer and Future Directions. Curr Oncol Rep (2017) 0.75
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol (2008) 4.78
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer (2009) 4.31
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer (2008) 4.18
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer (2004) 4.06
Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics (1982) 3.18
A computer program package for relative survival analysis. Comput Programs Biomed (1985) 3.10
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis (1978) 3.08
Risk of malignancy among patients with rheumatic conditions. Int J Cancer (2000) 2.70
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care (2000) 2.63
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat (2014) 2.61
Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect'. J Public Health (Oxf) (2005) 2.58
Effect of alcohol consumption on systemic markers of inflammation. Lancet (2001) 2.52
Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study. Br J Cancer (2002) 2.34
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol (2005) 2.31
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol (2004) 2.29
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax (2001) 2.24
Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Obesity, overweight and patterns of osteoarthritis: the Ulm Osteoarthritis Study. J Clin Epidemiol (2000) 2.12
Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis (2004) 2.11
The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev (2005) 2.08
Lung cancer: the importance of seeing a respiratory physician. Eur Respir J (2003) 2.08
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ (1994) 2.04
Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health (2001) 2.01
Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis (1999) 1.96
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ (1991) 1.84
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther (2009) 1.76
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol (2011) 1.73
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer (2001) 1.72
Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen (2010) 1.69
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer (2004) 1.68
Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE). Endoscopy (2010) 1.68
Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol (2006) 1.67
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer (2002) 1.66
Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol (2011) 1.64
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther (2008) 1.61
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Variations in the survival of adult cancer patients in Italy. Tumori (1997) 1.60
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Quality of life among long-term (≥5 years) colorectal cancer survivors--systematic review. Eur J Cancer (2010) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Cancer survival in Kampala, Uganda. Br J Cancer (2005) 1.58
Outcome-based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care (1989) 1.57
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". Am J Obstet Gynecol (1994) 1.53
Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life. J Pediatr (2000) 1.53
Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol (2000) 1.53
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Cancer in the offspring of fathers in hydrocarbon-related occupations. Br J Prev Soc Med (1976) 1.51
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50
Cancer information under threat: the case for legislation. Ann Oncol (2001) 1.49
Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods. Am J Epidemiol (2000) 1.48
Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology (2012) 1.48
Social class, parental education, and obesity prevalence in a study of six-year-old children in Germany. Int J Obes (Lond) (2005) 1.48
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology (2003) 1.47
Determinants of HIV counselling and testing participation in a prevention of mother-to-child transmission programme in rural Burkina Faso. Trop Med Int Health (2007) 1.46
Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in southern Germany. Pediatrics (1998) 1.46
[Management of patients with type 2 diabetes. Results in 12 practices of general practitioners]. Dtsch Med Wochenschr (2002) 1.46
[Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation]. Dtsch Med Wochenschr (2003) 1.46
Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study. Int J Cancer (1999) 1.46
Sequential treatment for recurrent localized prostate cancer. J Surg Oncol (2008) 1.45
Glycophorin A biodosimetry in Chernobyl cleanup workers from the Baltic countries. BMJ (1996) 1.45
Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol (2008) 1.45
Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol (2012) 1.45
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut (2011) 1.45
International variation in hip replacement rates. Ann Rheum Dis (2003) 1.45
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Reliability of radiographic grading of osteoarthritis of the hip and knee. Scand J Rheumatol (1997) 1.44
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg (2005) 1.44
Indications for total hip replacement: comparison of assessments of orthopaedic surgeons and referring physicians. Ann Rheum Dis (2006) 1.44
Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia (2006) 1.41
[Incidence and treatment of prostatic carcinoma in the region of the Comprehensive Cancer Center Amsterdam, 1989-1994]. Ned Tijdschr Geneeskd (1996) 1.40
Risk of leukaemia among children living near the Solway coast of Dumfries and Galloway Health Board area, Scotland, 1975-2002. Occup Environ Med (2006) 1.38
How to correct for chance agreement in the estimation of sensitivity and specificity of diagnostic tests. Methods Inf Med (1994) 1.38
[Internal radiotherapy in prostatic carcinoma; disappointing long-term results of retropubic Iodine-125 implantation]. Ned Tijdschr Geneeskd (1996) 1.38